GlassScriptPhysician profile
Christine M Browning
NPI 1093939852
$6,803.89
in general payments reported to CMS, 2019-2025
40 companies · $1,105 in 2025
The $1,105 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $970 · 2020: $367 · 2021: $837 · 2022: $1,155 · 2023: $1,403 · 2024: $967 · 2025: $1,105.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,475.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,475.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,323.72 | 2021-2025 | Cardiomems, Mitraclip, Amplatzer |
| Novartis Pharmaceuticals Corporation | $831.38 | 2019-2025 | |
| Amgen INC. | $443.49 | 2019-2024 | Repatha |
| Novo Nordisk INC | $374.25 | 2020-2025 | Ozempic, Wegovy, Rybelsus |
| Pfizer INC. | $293.46 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $274.55 | 2021-2025 | Verquvo |
| Astrazeneca Pharmaceuticals LP | $231.10 | 2019-2025 | Farxiga, Lokelma |
| Regeneron Healthcare Solutions, INC. | $230.24 | 2019-2025 | Evkeeza |
| Kestra Medical Technology Services, INC. | $229.31 | 2022-2025 | Assure Wcd |
| Janssen Pharmaceuticals, INC | $222.42 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $216.60 | 2019-2025 | Lifevest |
| Boston Scientific Corporation | $215.56 | 2021-2023 | Watchman Flx |
| Impulse Dynamics (USA) INC. | $181.78 | 2023 | Optimizer |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.52 | 2019-2024 | Jardiance |
| Sanofi-Aventis U.S. LLC | $148.50 | 2019-2022 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $143.10 | 2019-2021 | |
| Scpharmaceuticals INC. | $131.16 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $128.46 | 2019-2025 | Camzyos |
| Amarin Pharma, INC. | $120.20 | 2019-2020 | |
| Edwards Lifesciences Corporation | $106.83 | 2024 | Sapien 3 Ultra Resilia |
| Alnylam Pharmaceuticals INC. | $105.09 | 2024-2025 | Onpattro |
| Angiodynamics, INC. | $98.85 | 2025 | Auryon Laser System 100-120 Vac |
| Lundbeck LLC | $82.02 | 2019-2020 | |
| Tactile Systems Technology INC | $64.33 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $59.33 | 2025 | |
| Atricure, INC. | $56.52 | 2019-2023 | |
| Esperion Therapeutics, INC. | $45.02 | 2020-2025 | Nexletol |
| Philips North America LLC | $42.57 | 2025 | Diagnostic Ecg Service |
| Coala Life INC | $36.10 | 2021 | |
| Medtronic Vascular, INC. | $30.87 | 2019 | |
| Abiomed | $29.37 | 2024-2025 | Impella |
| Inspire Medical Systems, INC. | $22.67 | 2025 | Inspire |
| Akcea Therapeutics, INC. | $21.64 | 2019 | |
| Medtronic, INC. | $20.92 | 2022 | |
| Lilly USA, LLC | $17.68 | 2025 | Zepbound |
| Cashflow Solutions, LLC | $16.45 | 2024 | Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White, Pcd-51 731a (US) - White |
| Glaxosmithkline, LLC. | $16.21 | 2025 | Shingrix, Arexvy |
| Gilead Sciences, INC. | $13.88 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $12.29 | 2019 | |
| Bardy Diagnostics, INC. | $10.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Browning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.